BSGM Stock Overview
A medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
BioSig Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.34 |
| 52 Week High | US$6.80 |
| 52 Week Low | US$0.20 |
| Beta | 0.65 |
| 11 Month Change | -20.93% |
| 3 Month Change | -1.48% |
| 1 Year Change | -94.04% |
| 33 Year Change | -98.89% |
| 5 Year Change | -99.59% |
| Change since IPO | -99.58% |
Recent News & Updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08BioSig signs purchase deal with Kansas City's Overland Park Regional hospital
Jul 07BioSig: PURE EP Economics Trade Exhausted
Jun 14Shareholder Returns
| BSGM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -23.3% | -0.8% | 1.2% |
| 1Y | -94.0% | 20.4% | 30.2% |
Return vs Industry: BSGM underperformed the US Medical Equipment industry which returned 20.4% over the past year.
Return vs Market: BSGM underperformed the US Market which returned 30.2% over the past year.
Price Volatility
| BSGM volatility | |
|---|---|
| BSGM Average Weekly Movement | 15.9% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BSGM's share price has been volatile over the past 3 months.
Volatility Over Time: BSGM's weekly volatility has decreased from 31% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 4 | Anthony Amato | www.biosig.com |
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company’s product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy.
BioSig Technologies, Inc. Fundamentals Summary
| BSGM fundamental statistics | |
|---|---|
| Market cap | US$5.56m |
| Earnings (TTM) | -US$18.07m |
| Revenue (TTM) | US$40.00k |
138.9x
P/S Ratio-0.3x
P/E RatioIs BSGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSGM income statement (TTM) | |
|---|---|
| Revenue | US$40.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$40.00k |
| Other Expenses | US$18.12m |
| Earnings | -US$18.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.11 |
| Gross Margin | 100.00% |
| Net Profit Margin | -45,187.50% |
| Debt/Equity Ratio | 0% |
How did BSGM perform over the long term?
See historical performance and comparison